Daewon Pharmaceutical Co., Ltd. (KRX:003220)

South Korea · Delayed Price · Currency is KRW

7,850.00

-10.00 (-0.13%)

Sep 18, 2026, 3:30 PM KST

Market Cap	168.25B -40.7%
Revenue (ttm)	614.64B +1.8%
Net Income	2.63B -67.8%
EPS	109.91 -71.2%
Shares Out	21.43M
PE Ratio	39.01
Forward PE	7.48
Dividend	250.00 (3.19%)
Ex-Dividend Date	Dec 29, 2025

Volume	12,551
Open	7,990.00
Previous Close	7,860.00
Day's Range	7,830.00 - 8,000.00
52-Week Range	7,060.00 - 13,670.00
Beta	0.15
Analysts	Strong Buy
Price Target	14,666.67 (+86.84%)
Earnings Date	Nov 13, 2026

About Daewon Pharmaceutical

Daewon Pharmaceutical Co., Ltd., a pharmaceutical company, manufactures and sells medicines and medical supplies in South Korea. It offers various medicines for circulatory, respiratory, antibiotic, chemotherapy, and psychoneurosis use. The company’s principal products include Oramin-F Soft Cap, a multivitamin product; Pelubi Tablet, a NSAID product for pain relief; Freefol-MCT Inj., a microemulsion propofol for the anti-exogenous infectious bacteria; Megex-I Susp, a medicine that supplements subalimentation of cancer patients; Trigel Susp, a t... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1958

Employees 1,236

Stock Exchange Korea Stock Exchange

Ticker Symbol 003220

Full Company Profile

Financial Performance

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for 003220 stock is "Strong Buy." The 12-month stock price target is ₩14,667, which is an increase of 86.84% from the latest price.

Price Target

₩14,667

(86.84% upside)

Analyst Consensus: Strong Buy

Stock Forecasts